The combination therapy with EpCAM/CD3 BsAb and MUC-1/CD3 BsAb elicited antitumor immunity by T-cell adoptive immunotherapy in lung cancerCe Wang, Furong Li, Shang Chen et al.|International Journal of Medical Sciences|2021Cited by 8